These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23155429)

  • 41. Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1 alpha corticotropin-releasing hormone receptor.
    McEvoy AN; Bresnihan B; FitzGerald O; Murphy EP
    Arthritis Rheum; 2001 Aug; 44(8):1761-7. PubMed ID: 11508426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stress-induced barrier disruption of rat follicle-associated epithelium involves corticotropin-releasing hormone, acetylcholine, substance P, and mast cells.
    Keita AV; Söderholm JD; Ericson AC
    Neurogastroenterol Motil; 2010 Jul; 22(7):770-8, e221-2. PubMed ID: 20149111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stress triggers coronary mast cells leading to cardiac events.
    Alevizos M; Karagkouni A; Panagiotidou S; Vasiadi M; Theoharides TC
    Ann Allergy Asthma Immunol; 2014 Apr; 112(4):309-16. PubMed ID: 24428962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism.
    Vanuytsel T; van Wanrooy S; Vanheel H; Vanormelingen C; Verschueren S; Houben E; Salim Rasoel S; Tόth J; Holvoet L; Farré R; Van Oudenhove L; Boeckxstaens G; Verbeke K; Tack J
    Gut; 2014 Aug; 63(8):1293-9. PubMed ID: 24153250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
    Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
    Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mast cells as targets of corticotropin-releasing factor and related peptides.
    Theoharides TC; Donelan JM; Papadopoulou N; Cao J; Kempuraj D; Conti P
    Trends Pharmacol Sci; 2004 Nov; 25(11):563-8. PubMed ID: 15491778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corticotropin-releasing hormone stimulates NF-kappaB in human epidermal keratinocytes.
    Zbytek B; Pfeffer LM; Slominski AT
    J Endocrinol; 2004 Jun; 181(3):R1-7. PubMed ID: 15171702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice.
    Huang M; Pang X; Karalis K; Theoharides TC
    Cardiovasc Res; 2003 Jul; 59(1):241-9. PubMed ID: 12829195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of corticotropin-releasing hormone (CRH) on monocyte function, mediated by CRH-receptor subtype R1 and R2: a potential link between mood disorders and endothelial dysfunction?
    Wilbert-Lampen U; Straube F; Trapp A; Deutschmann A; Plasse A; Steinbeck G
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):110-6. PubMed ID: 16424794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A role for type 1alpha corticotropin-releasing hormone receptors in mediating local changes in chronically inflamed tissue.
    Ralph JA; Zocco D; Bresnihan B; Fitzgerald O; McEvoy AN; Murphy EP
    Am J Pathol; 2007 Mar; 170(3):1121-33. PubMed ID: 17322394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity.
    Rowe WB; Nicot A; Sharma S; Gully D; Walker CD; Rostène WH; Meaney MJ; Quirion R
    Neuroendocrinology; 1997 Aug; 66(2):75-85. PubMed ID: 9263204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mast cells and inflammation.
    Theoharides TC; Alysandratos KD; Angelidou A; Delivanis DA; Sismanopoulos N; Zhang B; Asadi S; Vasiadi M; Weng Z; Miniati A; Kalogeromitros D
    Biochim Biophys Acta; 2012 Jan; 1822(1):21-33. PubMed ID: 21185371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaB.
    Lezoualc'h F; Engert S; Berning B; Behl C
    Mol Endocrinol; 2000 Jan; 14(1):147-59. PubMed ID: 10628754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychological Stress Exacerbates Inflammation of the Ileum via the Corticotropin-Releasing Hormone-Mast Cell Axis in a Mouse Model of Eosinophilic Enteritis.
    Kanamori A; Tanaka F; Ominami M; Nadatani Y; Fukunaga S; Otani K; Hosomi S; Kamata N; Nagami Y; Taira K; Fujiwara Y
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterooligomerization between vasotocin and corticotropin-releasing hormone (CRH) receptors augments CRH-stimulated 3',5'-cyclic adenosine monophosphate production.
    Mikhailova MV; Mayeux PR; Jurkevich A; Kuenzel WJ; Madison F; Periasamy A; Chen Y; Cornett LE
    Mol Endocrinol; 2007 Sep; 21(9):2178-88. PubMed ID: 17536010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory effects of antipsychotic and anxiolytic agents on stress-induced degranulation of mouse dermal mast cells.
    Shimoda T; Liang Z; Suzuki H; Kawana S
    Clin Exp Dermatol; 2010 Jul; 35(5):531-6. PubMed ID: 19874365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuromedin U-induced anorexigenic action is mediated by the corticotropin-releasing hormone receptor-signaling pathway in goldfish.
    Maruyama K; Wada K; Ishiguro K; Shimakura S; Wakasugi T; Uchiyama M; Shioda S; Matsuda K
    Peptides; 2009 Dec; 30(12):2483-6. PubMed ID: 19699772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of corticotropin-releasing hormone (CRH) on endothelin-1 and NO release, mediated by CRH receptor subtype R2: a potential link between stress and endothelial dysfunction?
    Wilbert-Lampen U; Trapp A; Modrzik M; Fiedler B; Straube F; Plasse A
    J Psychosom Res; 2006 Oct; 61(4):453-60. PubMed ID: 17011352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mast cell corticotropin-releasing factor subtype 2 suppresses mast cell degranulation and limits the severity of anaphylaxis and stress-induced intestinal permeability.
    D'Costa S; Ayyadurai S; Gibson AJ; Mackey E; Rajput M; Sommerville LJ; Wilson N; Li Y; Kubat E; Kumar A; Subramanian H; Bhargava A; Moeser AJ
    J Allergy Clin Immunol; 2019 May; 143(5):1865-1877.e4. PubMed ID: 30439403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corticotropin-releasing hormone (CRH) depresses n-methyl-D-aspartate receptor-mediated current in cultured rat hippocampal neurons via CRH receptor type 1.
    Sheng H; Zhang Y; Sun J; Gao L; Ma B; Lu J; Ni X
    Endocrinology; 2008 Mar; 149(3):1389-98. PubMed ID: 18079206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.